Who we are
LipoCoat is a biotech company specialised in ‘bio-inspired’ coatings that improve the safety, comfort, and performance of devices with a focus on health and nutrition. Our pipeline comprises discovery and (pre)-clinical programmes in the medical device and drug discovery space. Our ambition is to become a leading biotech company dedicated to improving health and well-being through the discovery, development, and commercialisation of novel surface solutions.
We see a myriad of possibilities with our unique coating technology platform and have defined our strategic roadmap by way of contact lenses, catheters, and other implants- eventually developing a line of therapeutic coatings.
LipoCoat BV was established in September 2016 and is a spin-off company from the world renown MESA+ institute of nanotechnology based at the University of Twente. The company is based on the research conducted by Jasper van Weerd between 2010-2014, who at the time was a PhD student. Jasper took inspiration from nature and invented a new type of coating. A coating that mimics the cell membrane in such a way that surfaces in watery environments can exhibit anti-stick properties preventing such occurrences as microbial build-up. This invention was patented and LipoCoat landed its first strategic partner for the rigid contact lens coating in the year it was incorporated.
By 2017, the company had secured its first seed funding and expanded its management team with Raoul and Alain. By 2019 the company grew to 17 FTE, built its own lab facility across from the University of Twente campus, and became ISO certified- 13485. Also, we were selected to join the Johnson & Johnson JLabs incubator program. In 2020 LipoCoat secured a series A investment round and expanded its efforts to include the catheter application.
JASPER VAN WEERD,
Chief Executive Officer
Alain le Loux,
Chief Financial Officer
Chief Business Development Officer & Co-founder
Jasper van Weerd: Chief Executive Officer & Founder
Alain le Loux: Chief Financial Officer / Director of Strategy and Marketing & Co-founder
Raoul Oostenbrink: Chief Business Development Officer & Co-founder
SCIENTIFIC ADVISORY TEAM
Prof. Marcel Karperien
Scientific advisor & Founder
Prof. Pascal Jonkheijm
Scientific advisor & Founder
Philip Lavin, Ph.D. FASA FRAPS
Regulatory & Clinical trails expert
Anil Duggal, MD, FRCSC, FACS
Marcel Karperien: Scientific advisor & Founder
Pascal Jonkheijm: Scientific advisor & Founder
Philip Lavin: Regulatory & Clinical trails expert
Anil Duggal: Medical advisor
Dr. Duggal received his medical degree at McMaster University in Ontario, Canada. Following medical school, Dr. Duggal received a fellowship in Burns from the University of Alberta Firefighter’s Burn Treatment Unit and then completed his residency in Plastic and Reconstructive Surgery at McGill University in Montreal. His training then continued in Kentucky, as Dr. Duggal received a fellowship from the world-renowned Christine M. Kleinert Institute for Hand and Microsurgery at the University of Louisville. For the past three years, Dr. Duggal has worked as a hand and plastic surgeon at the University of Kentucky Medical Center and was a faculty member at the UK College of Medicine in Lexington.
Our headquarters are located at Kennispark Twente in Enschede – The Netherlands across the University of Twente campus. We have our own production lab facilities and have access to University Lab facilities where we do most of our R&D work. In Autumn 2019 LipoCoat joined the Johnson & Johnson JLabs incubator program and we are based at their Lab facilities in Beerse – Belgium.
LipoCoat HQ, Enschede (NL)
University of Twente, Enschede (NL)
J&J- JLabs, Beerse (BE)
The LipoCoat Group comprises of:
Investment Holding address:
LipoCoat International Holding BV
LipoCoat is proud to have the following partners in its ecosystem:
- Johnson & Johnson Innovation – JLABS
- Lloyd’s Register
- MESA+ Institute for Nanotechnology
- University of Twente
- Horizon 2020 – European commission
- LLX2 Investments
- NWO Take-Off 2
- Redmedtech Ventures